Trials / Conditions / Uterine Serous Carcinoma
Uterine Serous Carcinoma
5 registered clinical trials studyying Uterine Serous Carcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Azenosertib in Uterine Serous Carcinoma: Biomarker Study NCT06369155 | Joyce Liu, MD | Phase 2 |
| Recruiting | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988 | Volastra Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma NCT04814108 | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | Phase 2 |
| Completed | A Study of Adavosertib as Treatment for Uterine Serous Carcinoma NCT04590248 | AstraZeneca | Phase 2 |
| Completed | Trial of Maintenance With Niraparib- Uterine Serous Carcinoma NCT04080284 | Northwell Health | Phase 2 |